Sign in
CELC Stock Price, Chart, Stats & News
Celcuity Inc.
Save
Celcuity Inc. (CELC) does not currently pay a dividend.
3.87B
Market cap
–
Current P/E
–
Forward P/E
CELC chart
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -37.95% |
ROE | -203.17% |
D/E | 1.94x |
Interest coverage ratio | -5.75x |
CELC valuation
P/E | – |
P/S | – |
P/B | 55.40x |
P/CF | -36.34x |
P/FCF | -33.38x |
P/OCF | -36.34x |
PEG | 10.50x |
EV multiple | -33.65x |
About
Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it.
Similar securities
Based on sector and market capitalization
Report issue